Baker Brothers Advisors - REPROS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q3 2015$14,533,000
+3.9%
1,955,9440.0%0.13%
+8.9%
Q2 2015$13,985,000
-18.6%
1,955,944
-2.2%
0.12%
-14.0%
Q1 2015$17,180,000
-13.8%
2,000,0000.0%0.14%
-29.9%
Q4 2014$19,940,000
-27.5%
2,000,000
-28.0%
0.20%
-41.0%
Q3 2014$27,509,000
-42.8%
2,778,6540.0%0.35%
-41.3%
Q2 2014$48,071,000
-2.5%
2,778,6540.0%0.59%
-6.1%
Q1 2014$49,293,000
-3.1%
2,778,6540.0%0.63%
-12.6%
Q4 2013$50,849,000
-31.7%
2,778,6540.0%0.72%
-32.2%
Q3 2013$74,468,000
+45.3%
2,778,6540.0%1.06%
+4.3%
Q2 2013$51,266,0002,778,6541.01%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,132,367$8,096,0001.86%
DESTRIER CAPITAL MANAGEMENT LLC 329,030$2,353,0000.56%
RTW INVESTMENTS, LP 229,364$1,640,0000.48%
EDMOND DE ROTHSCHILD (SUISSE) S.A. 182,500$1,305,0000.41%
GENERAL AMERICAN INVESTORS CO INC 601,553$4,301,0000.35%
Baker Brothers Advisors 1,955,944$13,985,0000.12%
CQS Cayman LP 240,000$1,716,0000.10%
Gruss Capital Management LP 304,000$2,174,0000.08%
J. Goldman & Co LP 101,881$728,0000.04%
Squarepoint Ops LLC 18,800$134,0000.04%
View complete list of REPROS THERAPEUTICS INC shareholders